AEterna Zentaris Inc (AEZS)
1.96
-0.01
(-0.51%)
USD |
NASDAQ |
Apr 25, 16:00
1.96
0.00 (0.00%)
After-Hours: 20:00
AEterna Zentaris Profit Margin (Quarterly): -4.66K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.66K% |
September 30, 2023 | -138.2K% |
June 30, 2023 | -112.1% |
March 31, 2023 | -200.0% |
December 31, 2022 | -501.0% |
September 30, 2022 | -183.9% |
June 30, 2022 | |
March 31, 2022 | -174.0% |
December 31, 2021 | -302.7% |
September 30, 2021 | -183.7% |
June 30, 2021 | -131.6% |
March 31, 2021 | -87.41% |
December 31, 2020 | -55.41% |
September 30, 2020 | -887.5% |
June 30, 2020 | -5.07K% |
March 31, 2020 | 71.47% |
December 31, 2019 | -5.59K% |
September 30, 2019 | -117.0% |
June 30, 2019 | |
March 31, 2019 | -13.27K% |
December 31, 2018 | -368.2% |
September 30, 2018 | -378.4% |
June 30, 2018 | -1.55K% |
March 31, 2018 | 58.50% |
December 31, 2017 | -271.9% |
Date | Value |
---|---|
September 30, 2017 | -4.00K% |
June 30, 2017 | -1.05K% |
March 31, 2017 | -1.58K% |
December 31, 2016 | -2.70K% |
September 30, 2016 | -2.25K% |
June 30, 2016 | -7.30K% |
March 31, 2016 | -1.52K% |
December 31, 2015 | -9.82K% |
September 30, 2015 | -8.84K% |
June 30, 2015 | -7.66K% |
March 31, 2015 | -13.34K% |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | 31.11% |
December 31, 2012 | 31.48% |
September 30, 2012 | -91.81% |
June 30, 2012 | 60.77% |
March 31, 2012 | -120.4% |
December 31, 2011 | 40.16% |
September 30, 2011 | 11.33% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-138.2K%
Minimum
Sep 2023
71.47%
Maximum
Mar 2020
-9.20K%
Average
-183.9%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | -59.60% |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | -448.0% |
Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -58.89% |
Return on Assets | -35.48% |
Return on Invested Capital | -58.89% |
Gross Profit Margin (Quarterly) | 54.55% |
Operating Margin (Quarterly) | -5.29K% |
Return on Net Operating Assets | -85.24% |